GLOPID-R

GRIPP Coodinated Funding launches First Call

On September 4, GloPID-R launched the first call of its Global Research Pandemic Preparedness (GRIPP) coordinated funding mechanism, ‘Outbreak Ready: Accelerating Clinical Trial Site Readiness in LMICs’. Designed to leverage members’ existing investments in pandemic preparedness, GRIPP Call 1 aims to strengthen clinical trial capacity in low- and middle-income countries ensuring low-resource settings are research-ready to lead and deliver effective, equitable trials in future outbreaks.

The successful launch of this inaugural call marks a significant milestone in delivering on GloPID-R’s commitment to establish a coordinated, multinational funding mechanism to strengthen global pandemic preparedness.

A GRIPP informational webinar was co-hosted by the GloPID-R Secretariat and the EDCTP Association on 12th October, and was attended by over 100 researchers, clinicians, and global health professionals from more than 30 countries, predominantly from low- and middle-income regions. The session provided a detailed overview of the call, eligibility criteria, and application process, followed by a Q&A.

EU Flag

The GloPID-R Secretariat is a project which receives funding from the European Union’s Horizon Europe research and innovation programme under grant agreement No 101094188.